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ince 1989, when IBM researchers whimsical-
ly demonstrated a scientific breakthrough by con-
structing a 35-atom depiction of the company’s
logo, the ability to manipulate individual atoms has
spawned a tidal wave of research and development
at the nano (from the Greek word for “dwarf”)
scale. Nanomaterials are defined as having at least
one dimension of 100 nanometers or less—about
the size of your average virus. Nanotechnology—
the creation, manipulation, and application of
materials at the nanoscale—involves the ability to
engineer, control, and exploit the unique chemical,
physical, and electrical properties that emerge from
the infinitesimally tiny man-made particles. 
Nanoparticles behave like neither solids, liquids,
nor gases, and exist in the topsy-turvy world of quan-
tum physics, which governs those denizens small
enough to have escaped the laws of Newtonian
physics. This allows them to perform their almost
magical feats of conductivity, reactivity, and optical
sensitivity, among others. 
“That’s why nanomaterials are useful and inter-
esting and so hot right now,” says Kristen
Kulinowski, executive director for education and
policy at the Rice University Center for Biological
and Environmental Nanotechnology (CBEN).
“Being in this quantum regime enables new proper-
ties to emerge that are not possible or not exhibited
by those same chemicals when they’re much smaller
or much larger. These include different colors, elec-
tronic properties, magnetic properties, mechanical
properties—depending on the particle, any or all of
these can be altered at the nanoscale. That’s the
power of nanotech.”
Many observers not normally given to hyperbole
are calling nanotechnology “the next Industrial
Revolution.” The National Nanotechnology Initiative
(NNI), the interagency consortium overseeing the fed-
eral government’s widespread and well-funded nan-
otechnology activities, has predicted the field will be
worth $1 trillion to the U.S. economy alone by
2015—or sooner. Clearly, nanotechnology is poised to
become a major factor in the world’s economy and part
of our everyday lives in the near future. The science of
the very small is going to be very big, very soon. 
The Springboard
The first swells presaging the approaching nan-
otechnology tidal wave have already reached the
shore. Engineered nanoparticles are already being
produced, sold, and used commercially in products
such as sporting goods, tires, and stain-resistant
clothing. Engineered nanomaterials designed to
provide nontoxic, noncorrosive, and nonflammable
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Sneutralization of chemical spills or chemical
warfare agents are currently on the market.
Even sunscreens have gone nano—some
now contain nanoscale titanium dioxide or
zinc oxide particles that, unlike their larger,
opaque white incarnations, are transparent,
while still blocking ultraviolet rays effective-
ly. Fullerenes, which are used in commercial
products from semiconductors to coatings
for bowling balls, are being produced by the
ton at a Mitsubishi plant in Japan. 
Within a few years, experts say, these ini-
tial market forays will seem as quaint as
eight-track tapes. According to Mihail Roco,
senior advisor on nanotechnology to the
National Science Foundation (NSF) and
coordinator of the NNI, nanotechnology
will have four generations, or phases of
development. We’re already in the first, con-
sisting of “passive” nanostructures—simple
particles designed to perform one task. Roco
predicts the second phase will start in 2005,
with the appearance of commercial proto-
types of “active” nanostructures such as spe-
cial actuators, drug delivery devices, and new
types of transistors and sensors. 
As evidence of progress toward this sec-
ond phase, a team of Northwestern Univ-
ersity chemists led by Chad Mirkin recently
announced that they have discovered ways to
precisely construct nanoscale building blocks
that assemble into flat or curved structures.
The ability to create unusual nanostructures
such as bundles, sheets, and tubes holds
promise for new and powerful drug delivery
systems, electronic circuits, catalysts, and
light-harvesting materials. 
By 2010, Roco says, the third generation
will arrive, featuring nanosystems with
thousands of interacting components. And a
few years after that, the first “molecular”
nanodevices will appear,
devices that will be com-
posed of systems within
systems operating much
like a cell. 
As manufacturing
methods are perfected
and scaled up, nanotech-
nology is expected to
soon pervade, and often
revolutionize, virtually
every sector of industrial
activity, from electronics
to warfare, from medi-
cine to agriculture, from
the energy we use to drive
our cars and light our
homes to the water we
drink and the food we
eat. Nanotechnology is
today’s version of the
space race, and countries
around the globe are enthusiastically pouring
billions of dollars into support of research,
development, and commercialization. 
In terms of the environment and human
health, nanotechnology presents the same
conundrum as past major technological
advances: there may be enormous benefits in
terms of benign applications, but there are
inherent risks as well. What will happen
when nanomaterials and nanoparticles get
into our soil, water, and air, as they most
assuredly will, whether deliberately or acci-
dentally? What will happen when they
inevitably get into our bodies, whether
through environmental exposures or targeted
applications? The answers to those vital ques-
tions remain largely unanswered, although
some early findings are less than reassuring,
as evidenced by a recent study implicating
fullerenes in oxidative stress in the
brains of large-mouth bass [see
“Fullerenes and Fish Brains: Nano-
materials Cause Oxidative Stress,”
EHP 112:A568 (2004)]. 
Questions of another sort also need
to be answered. Is anyone looking at
these health and safety issues? And can
enough solid, reliable risk assessment
knowledge be gained in time to ensure
that the public will—or even that it
should—be comfortable with the pro-
liferation of the technology? Will the
paradigm shift smoothly into the nano
world, or will issues of safety and trust
surround nanotechnology with contro-
versy that may hinder its potential, as
has happened in the past with such
achievements as genetically modified
organisms (GMOs)?
Kulinowski expresses the nearly
universal sentiments of the field’s
advocates: “We think nanotechnology
has enormous potential to benefit society in
a whole variety of sectors and applications,
from the next cancer treatment, to environ-
mental applications, to energy—you name
it. So we don’t want to see that potential lim-
ited or eliminated by real or perceived risk
factors associated with engineered nanoma-
terials.” To ensure that nanotechnology
flourishes responsibly and with strong pub-
lic support, Kulinowski says, advocates
believe it’s very important to gather risk data
so that questions can be answered and prob-
lems addressed early on in the trajectory of
the technology development. 
Sean Murdock, executive director of the
NanoBusiness Alliance, a nanotechnology
trade association, thinks it is possible to avoid
past mistakes of rolling out a new technology
too far ahead of health and safety informa-
tion. “The risks are there, they’re real, but
they’re manageable,” he says. “And on bal-
ance, with the right processes in place, we’re
going to be able to deal with all of those risks,
we’re going to mitigate those risks, and we’re
going to realize the upside of the potential.”
Nanomedicine: A Tiny Dose for
Health
One of the most promising applications of
nanotechnology, known as nanomedicine,
involves the development of nanoscale tools
and machines designed to monitor health,
deliver drugs, cure diseases, and repair dam-
aged tissues, all within the molecular facto-
ries of living cells and organelles. The NIH
Roadmap for Medical Research—the
agency’s master plan to accelerate the pace
of discovery and speed the application of
new knowledge to biomedical prevention
strategies, diagnostics, and treatments—
contains a significant nanomedicine initia-
tive that will begin with the establishment
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Small learning curve. Self-assembly of gold polymer nanorods results
in a curved structure. The ability to control the size and curvature of
nanostructures could aid in applications in drug delivery and electronics.
For comparison’s sake. A micrograph shows a nanowire
curled into a loop in front of a human hair. Nanowires
can be as slender as 50 nanometers, about one-
thousandth the width of a hair.of 3–4 Nanomedicine Development
Centers. These multidisciplinary facilities
will serve as the intellectual and technologi-
cal centerpiece of the endeavor. Funding for
the centers of $6 million per year will begin
in September 2005.
Today, the initiative’s long-term goals
sound like scenarios straight out of Isaac
Asimov’s Fantastic Voyage: nanobots that can
search out and destroy cancer cells before
they can form tumors . . . nanomachines that
can remove and replace broken parts of cells
. . . molecule-sized implanted pumps that
can deliver precisely targeted doses of drugs
when and where they’re needed . . . even
“smart” nanosensors that can detect patholo-
gy or perturbation in any or every cell in the
body, and instantly communicate that infor-
mation to doctors. Science fiction may soon
become science fact—these and many other
nanomedicine innovations are currently in
development, and the NIH predicts that its
nanomedicine initiative will start yielding
medical benefits in as soon as 10 years. Roco
also foresees that fully half of all drug discov-
ery and delivery technology will be based on
nanotechnology by 2015. 
Experts predict that nanosensors will also
provide significantly improved tools to deter-
mine both internal and external exposures in
real time, assess risk, link exposure to disease
etiology, characterize gene–environment
interactions, and ultimately improve public
health. The NIEHS, through its extramural
grants and Superfund Basic Research
Program, is funding the research and devel-
opment behind many of these expected
innovations.
For example, with a Small Business
Innovation Research grant, the institute is
supporting Platypus Technologies of Mad-
ison, Wisconsin, in its work on smart
nanosensors designed to act as personal
dosimeters for real-time and cumulative
exposure to toxic compounds. Combining
scaled-down photo optics and nanomateri-
als to form a uniquely sensitive platform for
exposure detection, the initial prototype
device is intended to detect even very low
exposures to organophosphate pesticides.
The sensor, expected to be available com-
mercially within two years, is small, light-
weight, passive, inexpensive, and easily
operated—one immediate application will
be monitoring the chemical environments
of children. 
Platypus CEO Barbara Israel elaborates:
“Our product is ‘tunable’ for different antic-
ipated concentration ranges and monitoring
time periods. Therefore, it can be applied to
monitor workers for occupational exposure
to toxic compounds during manufacturing,
as well as to the monitoring of field exposure
of agricultural workers.” The company is also
developing sensors that will immediately
respond to the ambient presence of very low
concentrations of other toxic agents, and
expects that units will be networked by the
thousands in security systems at facilities
such as airports and train stations, as well as
having industrial applications. 
“This technology is going to revolution-
ize how we do business”—the business of
environmental health science, that is—
according to William Suk, director of the
Center for Risk and Integrated Sciences
within the NIEHS Division of Extramural
Research and Training. Suk oversees many of
the institute’s extramural grants involving
nanotechnology. “One of the real potentials
of this technology is to truly be able to
understand gene–environment interactions,
to be able to take the ‘omics’ revolution and
scale it down in such a way that you have a
comprehensive global approach to under-
standing how things fit together,” he says.
“We’re really looking at the use of these tech-
nologies in systems biology, to understand
how systems communicate—how cells com-
municate amongst themselves, and within
themselves, and with other cell systems
within our body. It’s all connected.” 
A wide variety of extraordinarily sophisti-
cated nanobiosensors fitting Suk’s vision are
well along in development among institute
grantees. For example, neurotoxicologist
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Martin Philbert at the University of Michigan
is perfecting a sensor that measures and identi-
fies chemical perturbations within the mito-
chondria of neurons, and may eventually allow
intervention or prevention of such cellular dis-
turbances. Roger Tsien, a professor of pharma-
cology, biochemistry, and chemistry at the
University of California, San Diego, is devel-
oping toxicity sensors that can indicate expo-
sures and the perturbations they cause at the
genomic level in real time. Kenneth Turtle-
taub, a scientist at Lawrence Livermore
National Laboratory, uses an accelerator
mass spectrometer to look at nanostructures
for biomarkers of exposure to carcinogenic
chemicals, characterizing perturbations at
the atomic level. According to Suk, these
and other nanodevices will be making major
contributions to the field of environmental
health within the next five years. When nan-
otechnology achieves its full impact, he says,
toxicogenomics will evolve beyond its infan-
cy and begin to fulfill its promise of signifi-
cant improvements in public health. 
Small Improvements in A Big World
Although research and development of envi-
ronmental applications is still a relatively nar-
row area of nanotechnology work, it is growing
rapidly, and nanomaterials promise just as daz-
zling an array of benefits here as they do in
other fields. Nanotechnology will be applied to
both ends of the environmental spectrum, to
clean up existing pollution and to decrease or
prevent its generation. It is also expected to
contribute to significant leaps forward in the
near future in environmental monitoring and
environmental health science. 
The Science To Achieve Results (STAR)
program of the U.S. Environmental Protection
Agency (EPA), administered by the agency’s
National Center for Environmental Research,
was an early investor in and promoter of envi-
ronmental applications of nanotechnology.
Beginning in 2001, the agency devoted a small
discretionary portion of its grant-making
budget to nanotechnology. “We decided to do
applications with respect to the environment
first,” says Barbara Karn, who oversees the
nanotechnology aspect of the program. “We
wanted to make a case for the new technology
being useful for the legacy issues of EPA.” 
Contaminated soil and groundwater are
among the most prominent of those legacy
issues, and there has been considerable
progress in nanotechnology-based remedia-
tion methods. Environmental engineer Wei-
xian Zhang of Lehigh University, a STAR
grantee who also receives funding from the
NSF, has been working since 1996 to develop
a remediation method using nanoscale metal-
lic particles, particularly iron nanoparticles,
which he has found to be powerful reductants.
“If any contaminant can be degraded or trans-
formed by reduction,” he says, “you can use
the iron nanoparticles.” He has been field-
testing the method since 2000, both in pilot
studies and at several industrial sites contami-
nated with such toxicants as polychlorinated
biphenyls, DDT, and dioxin, and the results
have been encouraging.
Zhang’s nanoremediation offers several
potential advantages over existing methods.
The implementation is very simple—the
nanoparticles are suspended in a slurry and
basically pumped directly into the heart of a
contaminated site. By comparison, current
methods often involve digging up the soil and
treating it.“You can inject [the nanoparticles]
in some difficult situations, for example,
under a runway, under a building, or other
sites where typical engineering methods may
not be feasible,” says Zhang.  
Nanomaterials have a large proportion of
surface atoms, and the surface of any materi-
al is where reactions happen. Because of
nanoparticles’ huge surface area and thus
very high surface activity, workers can poten-
tially use much less material. The amount of
surface area also allows a fast reaction with
less time for intermediates to form—a boon
in biodegradation, where the intermediate
products are sometimes more toxic than the
parent compound. Finally, Zhang’s method
is also much faster. “Because of the higher
activity, it takes much less time to achieve
remediation goals than conventional tech-
nology, which, using biological processes,
can take years,” he says. With the iron
nanoparticles, in most cases the team saw
contaminants neutralized into benign com-
pounds in a few days.
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Zhang is currently focusing on scaling up
production of the iron nanoparticles to make
them more cost-competitive, and plans to
establish a business based upon his techniques.
His is just one of dozens of nanoremediation
methods being developed, but is probably the
closest to large-scale deployment—he expects
that within a year or two, there will be tens to
hundreds of projects using the metallic
nanoparticle technology. And this type of “pas-
sive” application is only the beginning. 
“In the future,” says Zhang, “we’ll have
more sophisticated devices that can function
not only as a treatment device, but also as a
sensor with detection functions and commu-
nication capability that you can put into the
ground and get feedback on different envi-
ronmental parameters.” That type of device
will give remediators the ability to determine
when a treatment has been adequately com-
pleted, currently a problematic determination
to make. Similar nanosensors that will allow
real-time in situ detection and analysis of pol-
lutants are being developed for environmental
monitoring purposes.
The environmental benefits portended by
nanotechnology go farther still. Improvements
in membrane technology afforded by nanoma-
terials, for example, will allow greatly enhanced
water filtration, desalination, and treatment of
wastewater through finer and “smarter” selec-
tive filtration. The technology that is expected
to be proliferated is also anticipated to be very
simple and very inexpensive. These develop-
ments are expected to eventually go a long way
toward ameliorating the shortages of clean,
plentiful, low-cost drinking water that plague
many areas of the world.
Murdock says nanotechnology is
also likely to help prevent a great deal of
pollution in the future by affording the
opportunity to “reinvent the energy
infrastructure that powers the economy,
which ultimately has been driving many
of the issues that environmentalists . . .
have been worrying about over the past
few decades.” Nanoscale materials and
devices could result in game-changing
breakthroughs in energy production
through advances in hydrogen and solar
energy, and could even beget vast
improvements in the efficiency and
cleanliness of carbon-based energy.
There is serious talk, for example, that
nanotechnology could make it possible
to sustainably expand the use of coal in
energy production, using a nanocatalyst
that turns coal directly into cleaner-
burning diesel fuel and gasoline.
On  the other hand, nano-based
lighting is already a reality—traffic
lights across the country now use tiny
light-emitting diode displays that
remain in service longer and use less
energy than bulbs. The NNI has projected
that widespread proliferation of the technolo-
gy for home and office lighting could cut
U.S. energy consumption by as much as
10%, dropping carbon emissions by up to
200 million tons annually. 
With their extremely high reactivity,
nanomaterials may also enable “green” chem-
istry and “exact” manufacturing, in which
chemicals and other products are manufac-
tured from the bottom up, atom by atom.
This development would allow the creation of
less-toxic products while reducing or eliminat-
ing both hazardous waste and the need for
large quantities of toxic raw materials—so-
called source reduction. The green chemistry
concept applies to the production of nanopar-
ticles themselves. University of Oregon
chemist James Hutchinson recently patented
a more benign (and faster and cheaper)
method for producing gold nanoparticles,
which are particularly important in the semi-
conductor industry. 
Karn is excited by this and similar devel-
opments: “We really have such an opportuni-
ty here with this new technology, to make it
without waste, to make the particles in an
environmentally friendly way, so that we
don’t have to worry about the emissions [and]
we  don’t have to worry about the cleanup
afterwards.”
A Yellow Light
The same properties that confer such incredi-
ble utility to engineered nanoparticles are
those that raise concerns about the nature of
their interactions with biological systems: their
size, their shapes, their high reactivity, how
they are coated, and other unique characteris-
tics could prove to be harmful in some physi-
ologic circumstances. Several recent studies
have appeared in the literature showing that
some nanomaterials are not inherently benign.
Some can travel readily through the body,
deposit in organ systems, and penetrate indi-
vidual cells, and could trigger inflammatory
responses similar to those seen with ambient
nanoparticles—better known in environmen-
tal science as ultrafine particles—which are
known to often be far more toxic than their
larger counterparts. The primary difference
between ambient and engineered nanoparti-
cles is that the former have widely varying
shapes, sizes, and compositions, whereas the
latter are single, uniform compounds.
University of Rochester environmental
toxicologist Günter Oberdörster has shown in
rodent studies, published in June 2004 in
Inhalation Toxicology, that inhaled nanoparti-
cles accumulate in the nasal passages, lungs,
and brains of rats. And in the January 2004
issue of Toxicological Sciences, National
Aeronautics and Space Administration scien-
tist Chiu-Wing Lam recently reported that a
suspension of carbon nanotubes (one of the
most widely used and researched engineered
nanoparticles) placed directly into mouse
lungs caused granulomas, unusual lesions that
can interfere with oxygen absorption. David
Warheit, a DuPont researcher, conducted a
similar experiment in rats, reported in the
same issue of Toxicological Sciences, and dis-
covered immune cells gathering around
clumps of nanotubes in the animals’ lungs. At
the highest dose, 15% of the rats essentially
suffocated due to the clumping of the nan-
otubes having blocked bronchial pas-
sages. Although Lam’s and Warheit’s
studies did not reflect potential real-
world exposures, their results were
nonetheless troubling, showing at least
that nanotubes are biologically active and
possibly toxic. 
A study published in the July 2004
issue of EHP documenting oxidative
stress (a sign of inflammation) in the
brains of largemouth bass exposed to
aqueous fullerenes has received perhaps
the most attention and raised the most
warnings of any nanomaterial health
implication experiment to date. Eva
Oberdörster (Günter’s daughter), an envi-
ronmental toxicologist at Southern
Methodist University, describes herself as
“shocked” at the amount of mainstream
national press coverage the study has
received. She is quick to stress that
although some reports have described
“brain damage” or even “severe brain
damage” in the fish, she has actually char-
acterized her findings as “significant dam-
age in the brain, which is very different
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Probing insights. Nanoprobes studded with molecules that
bind ions such as zinc, calcium, and potassium are injected into
cells to reveal the patterns of ion exchange that make cells func-
tion. Computer models are used to interpret the fluorescent sig-
natures probes emit when they capture a target ion.from brain damage.” After 48 hours’ exposure
to fairly high doses of fullerenes, the fish prob-
ably had the same effect as a very bad
headache, she says, but they did survive the
exposure. As to the inflammation, Oberdörster
says it could have been an appropriate response
to a foreign stressor or a symptom of real phys-
iologic damage. She plans to study this issue
further in gene microarray experiments
designed to more thoroughly characterize the
inflammatory response involved, and to see
whether the fish might actually metabolize and
excrete the particles.
Oberdörster has described the findings as
“a yellow light, not a red one,” and explains
further that there are some indications from
the inhalation and fish studies that there is a
potential for nanoparticles to react with tissues
and create inflammation. “So the next step
then is to look at it in a broader spectrum
before we bring all these products out into the
market, to make sure that they are safe so that
consumers are protected,” she says.
Kulinowski feels that the early studies
raise more questions than answers, and she
cautions against overinterpreting individual
studies. She is optimistic, however, that with
technological advances, the potential negative
impacts of engineered nanoparticles can be
minimized or eliminated altogether. “The
good news I see is that with the control we
have over engineered nanoparticles, we may
be able to engineer them to confer the bene-
fits, but not the risks, not the hazards.” Again,
it’s all about the surface, she says: “If we can
control surface properties of nanoparticles, we
may be able to tune out the toxicity. . . . It’s
like sliding a dimmer switch on a lamp—you
can just tune it right down to pretty much
beyond our capacity to measure it.”
Big Issues for Nanotechnology
Nanotechnology accomplishments could
soon affect every person on the planet. But the
opinion is virtually unanimous,
among advocates and skeptics alike,
that the full realization of nanotech-
nology’s potential benefits is threat-
ened by ongoing concerns about the
potentially negative effects nanoma-
terials could have on human health
and the environment. Applications
are being vigorously pursued. The
question is, will knowledge of the
implications keep pace?
In  August 2002, the Action
Group on Erosion, Technology, and
Concentration (ETC Group), a
Canadian environmental activist
group that played a key role in the
battle against acceptance of GMOs
in the 1990s, called for a worldwide
moratorium on research and com-
mercialization of engineered nano-
materials until there are protocols in place to
protect workers, including lab workers. They
cited a dearth of research data about the
potential negative implications of nanomate-
rials, and the lack of specific regulatory over-
sight or established best practices in the han-
dling of nanoparticles in either the laboratory
or the manufacturing setting.
Perhaps coincidentally, in the two years
since the ETC Group’s moratorium call there
has been a palpable upsurge in research and
bureaucratic activity regarding those missing
pieces of the puzzle. All of the stakeholders,
casting a weather eye at the GMO experience,
apparently agree that the bountiful benefits of
nanotechnology cannot be harvested without
full and transparent characterization of the risks
they could pose to human health and the envi-
ronment.
“We’re  much better off over the long
haul if we make sure that we address con-
cerns and issues proactively,” says Murdock.
“That doesn’t mean we should be hypersen-
sitive and shy away from exploring new
areas, because fundamentally
we only make progress through
exploration. But it needs to be
balanced and tempered with a
continuous examination of the
implications.” 
Roco, who has been instru-
mental in the NNI’s ongoing
attention to both safety impli-
cations and the potential socie-
tal impacts of nanotechnology
worldwide, agrees that the time
for responsible risk assessment
is now: “This is no longer
something you do after the fact,
after you do the other research,
but has to be done from the
beginning, to be an integral
part of the research. You have to
look at the whole cycle of activ-
ity, not only at the first phase when you cre-
ate something.” 
The CBEN has been investigating the
environmental fate of nanoparticles since its
inception in 2001 as one of six Nanoscale
Science and Engineering Centers established
by the NSF, and Kulinowski has noted the
recent explosion in interest and funding in
nanotech environmental health and safety
research. “We have seen tremendous move-
ment on this issue over the last year and a half,
from the point where we almost felt like we
were calling out into the darkness, to where
people are now moving forward independent-
ly,” she says. “Most encouraging has been the
federal government’s response. We’ve also seen
a tremendous response from industry . . . that
gives us hope that as we move toward com-
mercialization of nanotechnology products,
these questions will be addressed early on in
the development, before or when products
come to market.”
Critics and even some participants main-
tain that funding of implications research is
still inadequate in proportion to the nearly $1
billion the government is currently investing in
nanotechnology development. But efforts to
better understand the implications of nan-
otechnology are clearly gaining momentum.
Important new research initiatives are getting
under way, and coordination and collaboration
are increasing among the federal regulatory
agencies and research organizations involved. 
The NNI is the central locus, with a num-
ber of agencies participating. Representatives
from several of those agencies, including the
NIEHS, the EPA, and the National Institute
for Occupational Safety and Health
(NIOSH), have formed a working group on
the environmental and health impacts of
nanotechnology. The group meets monthly to
share knowledge, coordinate activities, identify
research gaps and goals, and address urgent
issues such as regulation and nomenclature. 
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Shapes and sizes. A visualization of a nanohydraulic pis-
ton consists of common nanotechnology components
including a carbon nanotube (blue), helium atoms (green),
and a "buckyball" molecule (gray). 
Tiny beach umbrellas. A titanium dioxide microsphere
(approximately 1–50 microns in diameter) with closed-packed
spherical inclusions functions in sunscreens as a small “pho-
tonic crystallite,” scattering light very effectively.Environmental Health Perspectives • VOLUME 112 | NUMBER 13 | September 2004 A 747
Two further major research initiatives
designed to establish fundamental knowledge
about the toxicologic properties of engineered
nanomaterials are in their initial stages. Both
will contribute significantly to the knowledge
base and allow more rational risk assessment
in the future.
The first of these major initiatives arose
from the CBEN’s 2003 nomination of
nanomaterials for study by the National
Toxicology Program (NTP). The NTP,
which is headquartered at the NIEHS, has
embarked upon a research program involv-
ing safety studies of representative manufac-
tured nanomaterials. “The aim of our pro-
gram,” says Nigel Walker, lead scientist of
the investigation, “is actually to help guide
the nanomaterial industry in identifying the
key parameters that lead to biocompatibility
of nanomaterials, versus toxicity of nanoma-
terials, so that we can avoid having problems
such as the genetically modified food situa-
tion, where the industry and the technology
got ahead of the biocompatibility issues.” 
The NTP program will focus initially on
studies of single-walled carbon nanotubes, tita-
nium dioxide, quantum dots (fluorescent
semiconductor nanocrystals used in imaging
equipment), and fullerenes. Because the most
likely route of exposure to those nanomaterials
as they are used today is through the skin, sev-
eral studies will concentrate on dermal toxici-
ty. Other exposure routes will be examined as
well, however, all looking at general, acute,
subchronic, and chronic levels of exposure. 
One of the broad goals of the NTP initia-
tive is to create models of nanomaterial chem-
ical, physical, and pharmacokinetic properties
that can be used to help evaluate new engi-
neered nanostructures as they come along.
According to John Bucher, deputy director of
the NIEHS Environmental Toxicology
Program, the purpose of this initiative is not
to prevent or understand the toxicity of every
material that can be manufactured under the
“nano” rubric. Instead, he says, “What we’re
trying to do is understand some of the funda-
mental properties of nanomaterials—how
they move, what kind of toxicities they have,
what kinds of organ systems are generally tar-
geted, what the effects of surface coatings are.
. . . We’re not trying to make the world safe
from nanotechnology, nor do we believe that
the world is necessarily at great risk from
nanomaterials at this moment, or potentially
even in the future. But the total absence of
any information makes this an area that we
just have to pursue.”
The NTP, in association with the Uni-
versity of Florida, is also planning a workshop
for November 2004 designed to bring togeth-
er scientists from the toxicology community,
environmental engineers, and representatives
of the pharmaceutical and chemical industries.
The workshop will focus on questions about
how best to assess exposure to nanomaterials
and evaluate their toxicity and safety. 
Walker thinks these efforts are timed per-
fectly. “If we’d tried to do this two or three
years ago, we may actually have been targeting
things that weren’t important,” he says. “You
don’t want to be too early on the curve, but
then you don’t want to be too late. This is
about the right time . . . and we are being very
open about how things are moving along,
because the NTP is completely open, and all
the data is ultimately the public’s.”
The second major initiative—research on
occupational health risks associated with man-
ufacturing and using nanomaterials—is being
spearheaded by NIOSH. The institute recent-
ly organized a Nanotechnology Research
Center to coordinate, track, and measure out-
comes, and disseminate the output of nan-
otechnology-related activities throughout the
institute. 
NIOSH has also undertaken a five-year
multidisciplinary initiative known as the
NIOSH Nanotechnology and Health and
Safety Research Program. As with the NTP’s
efforts, the idea is to characterize risks early in
the industry’s development, and the workplace
is the most likely location of exposures at pres-
ent. “There is some concern that these materi-
als are of unknown effect, and there is interest
in getting generalized industrial hygiene, gen-
eralized control measures, and best work prac-
tices involved early on,” says researcher
Vincent Castranova, who is principal investi-
gator for the program’s coordinating project as
well as a separate study exploring particle sur-
face area as a dose metric. “Normally, interest
in these elements has come after proof of dis-
ease outcome. This is one case where the con-
cerns are sufficient to cause the industry and
the governmental agencies to try to get good
work practices and prevention measures up
front, before we know full health outcomes.” 
Another NIOSH scientist, Andrew
Maynard, is investigating methods of charac-
terizing and monitoring airborne nanoparti-
cles. “Part of my project,” says Maynard, “is
developing and using the characterization
techniques, so that we can understand very
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Nanotech-Knowledge-y
Centers and Initiatives
National Nanotechnology Initiative (NNI)
Consortium of 19 agencies oversees the federal govern-
ment’s widespread and well-funded nanotechnology
activities.
http://www.nano.gov/
Center for Biological and Environmental Nanotechnology
(CBEN)
The CBEN, housed at Rice University in Houston, was
begun in 2001 as one of six Nanoscale Science and
Engineering Centers established by the NSF.
http://www.ruf.rice.edu/~cben/
National Institute for Occupational Safety and Health
(NIOSH)
NIOSH is particularly interested in nanomaterials with
regards to occupational safety and health. This page
includes information on the NIOSH Nanotechnology
Health and Safety Research Program and the NIOSH Nano
technology Research Center.
http://www.cdc.gov/niosh/topics/nanotech/
NIH Roadmap for Medical Research: Nanomedicine
The NIH Roadmap for Medical Research provides a frame-
work for NIH research priorities in upcoming years. The
roadmap contains a significant nanomedicine initiative
that includes the establishment of multidisciplinary Nano
medicine Development Centers.
http://nihroadmap.nih.gov/nanomedicine/index.asp
Chemical Industry Vision2020 Technology Partnership
This industry-led consortium aims to accelerate innovation
and technology development in the chemical industry. The
consortium, in cooperation with the NNI and the US
Department of Energy Office of Energy Efficiency and
Renewable Energy, released a comprehensive white paper
in 2003 called the Chemical Industry R&D Roadmap for
Nanomaterials By Design: From Fundamentals to Function.
http://www.chemicalvision2020.org/pdfs/
nano_roadmap.pdf
National Toxicology Program (NTP) Nanotechnology Safety
Assessment
The CBEN nominated nanoscale materials for study by the
NTP. Based on the nomination, the NTP is developing
materials and protocols to test a broad spectrum of
nanoscale materials for toxicity in animal models over the
next several years.
http://www.niehs.nih.gov/oc/factsheets/nano.htm
Other Resources
NanoBusiness Alliance
This nanotechnology trade association is developing a
range of initiatives to support and strengthen the
nanotechnology business community.
http://www.nanobusiness.org/
Action Group on Erosion, Technology, and Concen-
tration (ETC Group)
This Canadian group of environmental activists has
called for a worldwide moratorium on research and
commercialization of engineered nanomaterials. 
http://www.etcgroup.org/
Recent and Upcoming Events
Technology and Environmental Health: Implication of
Nanotechnology Public Discussion
Participants at this May 2004 meeting of the Institute
of Medicine Roundtable on Environmental Health Sci-
ences, Research, and Medicine discussed human and
environmental health implications of nanotechnology
as well as legislative and societal issues.
http://www.iom.edu/subpage.asp?id=19612
The International Dialog on Responsible Research and
Development of Nanotechnology 
The NNI brought together the leaders of nanotech-
nology programs from countries around the world at
this June 2004 workshop.
http://www.nsf.gov/home/crssprgm/nano/
dialog.htm
First International Symposium on Occupational Health
Implications of Nanomaterials
This workshop, convened by NIOSH, the U.K. Health
and Safety Laboratory, and the U.K. Health and Safety
Executive, will convene in the United Kingdom in
October 2004 to discuss workplace issues related to
nanomaterials.
http://www.hsl.gov.uk/news/nanosy mp.htm
The NTP, in association with the University of
Florida, is also planning a workshop for November
2004 to focus on questions about how best to assess
exposure to nanomaterials and evaluate their toxici-
ty and safety.Environmental Health Perspectives • VOLUME 112 | NUMBER 13 | September 2004 A 749
precisely the chemical and physical nature of
the particles, and also the concentration of the
particles being used in these experiments. Also,
we will look at how we can effectively monitor
exposures in the workplace, so that we can
have simple, robust, inexpensive techniques
that people can use in the workplace.” 
Although dermal exposure to nanomate-
rials is occurring as a result of their use in
sunscreens and some cosmetics, inhalation is
suspected to be the most likely route of expo-
sure in the workplace, so other projects in the
program will focus on pulmonary toxicity
questions, particularly with respect to carbon
nanotubes. Those questions will be tricky,
again due to the unique attributes of nanoma-
terials—they are technically ultrafine parti-
cles, but can they be judged the same way? 
“This is one of the big areas of debate at
the moment,” says Maynard. “To what extent
do you treat engineered nanoparticles as just
another ultrafine particle? It’s fair to say that
most of our concerns over nanomaterials are
being driven by our experiences with ultrafine
particles, which are substantially more inflam-
matory and toxic than fine particles.” 
“Another issue that is unresolved is that
these nanoparticles tend to aggregate, and the
aggregates often tend not to be under a hun-
dred nanometers in diameter,” adds Castra-
nova. “So do they then behave as fine particles
rather than ultrafine? That depends on
whether they disaggregate either in handling
or once they’re in the lung, which is
unknown. Their ability to enter the lungs, to
cross the air–blood barrier, or to cause inflam-
mation would be affected by [disaggregat-
ing].” NIOSH is helping to organize the First
International Symposium on Occupational
Health Implications of Nanomaterials, which
will convene in the United Kingdom in
October to discuss these issues.
The Ripple Effect
The NTP and NIOSH initiatives are the
major new programs in the works, but a great
deal of activity is continuing or beginning in
other circles as well. The NNI is expanding its
support of implications research, and recently
held a landmark international meeting that
brought together the leaders of nanotechnolo-
gy programs in 25 countries and the Euro-
pean Union. The International Dialog on
Responsible Research and Development of
Nanotechnology took place 17–18 June 2004
in Arlington, Virginia, and was designed to
help develop a global vision of how the tech-
nology can be fostered with the appropriate
attention to and respect for concerns about
the societal issues and environmental, health,
and safety implications. 
Roco, who called the meeting “a historic
event,” proposed the establishment of an
ongoing international organization dedicated
to responsible nanotechnology development.
Participants agreed to form a “preparatory
group” charged with exploring possible
actions, mechanisms, timing, institutional
frameworks, and principles involved in con-
structing a permanent institution designed
to ensure international dialogue, coopera-
tion, and coordination in nanotechnology
research and development. 
ETC Group executive director Pat
Mooney reacted favorably to the gathering as
well: “That’s the first time we’ve had an inter-
national meeting like this, and I think it’s a
very encouraging sign.”
Encouraging signs of commitment and
progress were also evident at two other land-
mark events held earlier this year. In March,
the NIEHS held a workshop called Tech-
nologies for Improved Risk Stratification and
Disease Prevention that brought together a
panel of experts to formulate specific recom-
mendations on how the institute should incor-
porate nanotechnology into its research agenda
in the coming years. Participants embraced the
idea that the NIEHS should lead the way in
developing a single small-scale platform to
detect individual chemical exposures, elimi-
nate toxicants from the system, and intervene
to reverse any harmful effects that might have
been initiated by the exposure. Then, in May,
a one-day public discussion was held by the
Institute of Medicine’s Roundtable on
Environmental Health Sciences, Research,
and Medicine, in which experts and members
of the public explored the issues raised by nan-
otechnology from a public health perspective.
The discussion illuminated potential public
health benefits while acknowledging recent
toxicological concerns. Events such as these
serve to inform the scientific community and
the public alike, encouraging the responsible
development of the technology.
Recognizing the enormous opportunities
at hand, the chemical industry is also placing a
high priority on nanotechnology implications
research. A consortium called the Chemical
Industry Vision2020 Technology Partnership,
in cooperation with the NNI and the U.S.
Department of Energy Office of Energy
Efficiency and Renewable Energy, released a
comprehensive white paper in 2003 titled
“Chemical Industry R&D Roadmap for
Nanomaterials by Design: From Funda-
mentals to Function.” This document calls for
an unprecedented level of cooperation and col-
laboration among U.S. chemical companies to
foster the long-term success of the nanochem-
ical industry, and stresses that environment,
safety, and health knowledge will be an essen-
tial component. “The anticipated growth in
nanoparticle utilization warrants parallel
efforts in hazard identification, exposure eval-
uation, and risk assessment,” the paper states.
“Chemical companies are prepared to serve a
major role in this process as leaders in charac-
terizing materials, identifying their potential
risks, and providing guidelines for their safe
and effective utilization.”
The EPA’s STAR program is planning to
award new grants soon in nanotechnology
implications research, and the CBEN is con-
tinuing its work on what it calls “the wet–dry
interface”—the interactions between engi-
neered nanomaterials and systems that are
active in aqueous or water-based environ-
ments, including ecosystems and living beings.
“We have several research projects we would
characterize as implications research,” says
Kulinowski, “looking at what happens when
nanomaterials get into the soil or into a water
supply.” By understanding how nanoparticles
(which are typically not soluble in water, hence
the “dry” side) interact with aqueous environ-
ments (the “wet” side), the researchers hope to
create technologies that will improve human
health and the environment, such as biocom-
patible nanoparticles or nanostructured cata-
lysts that will break down organic pollutants.
The wet–dry interface also plays a major role
in determining the environmental fate and
transport of nanomaterials.
Regulatory agencies such as the EPA, the
FDA, and the Occupational Safety and Health
Administration are all participating in the
NNI, following the progress of the research
carefully, and building their own knowledge
bases with an eye toward the eventual develop-
ment and implementation of nano-specific reg-
ulatory frameworks within their purviews. At
present the consensus seems to be that existing
regulations are sufficiently robust to appropri-
ately address concerns related to nanomateri-
als, but as risks and hazards are characterized in
more detail, that stance could change.
Even the ETC Group, although it has not
rescinded its call for a moratorium, seems
encouraged by recent progress. “We do feel like
we have had a reasonable response—as reason-
able as to be expected—from the govern-
ments,” says Mooney, “and that there is work
under way to try to correct the problems that
we have identified.” Mooney says that as indi-
vidual nations put nano-specific laboratory
protocols into place, his group will no longer
call for a moratorium in those countries.
It appears that all of this research activity is
reaching critical mass at just the right time.
The nanotechnology bullet train has left the
station with the power to take us to some mag-
ical places we’ve barely even dreamed of.
Although public distrust of the technology
could potentially derail the train, many passen-
gers are hoping that increased understanding
of both its potential benefits and dangers will
keep it on track and allow the journey toward
discovery to continue. 
Ernie Hood
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